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Ribonucleases (RNases) H1 and H2 are endonucleases that hydrolyze the RNA strand of 
RNA-DNA hybrids forming at the chromosomal level as well as extra-chromosomal 
hybrids. Extra-chromosomal RNA-DNA hybrids can frequently occur in cells as 
intermediate structures in the process of reverse transcription and generation of cDNA by 
retrotransposition. It is known that mutations in RNase H2 are found in        -          
syndrome (AGS) patients. AGS is a rare but severe immune-mediated 
neurodevelopmental disorder. Currently, the mechanism by which defects in RNase H2 
cause AGS is still unclear. We hypothesized that defects in RNases H, including those 
associated with AGS can trigger the accumulation of extra-chromosomal RNA-DNA 
hybrids. Thus, we speculate that increased stability of such free RNA-DNA hybrid 
structures could be a likely trigger for stimulating the autoimmune system, mimicking a 
viral infection in AGS patients. RNase H2 protein subunits of human and yeast 
Saccharomyces cerevisiae RNase H2 proteins have conserved amino acid sequences. 
Based on the similarity between human and yeast RNase H2, we thought to utilize S. 
cerevisiae as a research model to generate and study several AGS-related mutants. 
Initially, we set up an assay to detect retrotransposition activity in the budding yeast by 
introducing a recombinant DNA which includes a Ty1 retrotransposable element fused to 
an inactive his3 marker gene. To test whether the retrotransposition assay works in our 
yeast strains, we treated yeast cells with phosphonoformic acid (PFA) or knocked out 
DBR1 gene coding for the RNA lariat debranching enzyme. Both approaches strongly 
reduced the frequency of retrotransposition in our strains, demonstrating that the system 
was working as expected. Next, we examined whether yeast cells with defective forms of 
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RNases H or AGS-orthologous mutants of RNase H2 had altered retrotransposition 
activity compared with cells with wild-type RNases H. Results showed that the 
retrotransposition activity was repressed in the absence of both types of RNase H. In 
addition, AGS-related mutants showed decreased retrotransposition frequencies when 
RNase H1 was also knocked-out. These findings are relevant to uncover the mechanism 
























1.1 AICARDI-GOUTIÈRES SYNDROME 
In 1984, Aicardi-Goutières syndrome (AGS) was first described by Jean Aicardi and 
Françoise Goutières, who initially observed that eight children from five families 
underwent a neurodevelopmental disorder of the central nervous system [1].  In four 
years, Lebon found that increased levels of antiviral cytokine interferon-α (IFN-α),    
integral defense organization of cells against viral infections, was observed in infant 
patients and attributed to mimicked viral infection [2]. This syndrome is characteristically 
classified as a congenital and inflammatory disease. Some AGS-inherited infants show 
abnormal physical and molecular features at birth, such as elevated liver enzymes, 
thrombocytopenia, and enlarged liver and spleen [3]. In general, symptoms and signs of 
AGS are seen in few weeks after birth [3, 4]. About 40% of AGS patients suffer from 
painful and itchy skin lesions on their ears, fingers, and toes (Figure 1-1). AGS is also 
accompanied by brain dysfunction arising from cerebral calcification white matter 
abnormalities, and cerebral atrophy. As the result, AGS patients generally have a small 
head due to slow growth of brain and skull and undergo a phase of inflammation and 
continuous tissue damage in the central nerve system. Due to the severe impacts on the 















Figure 1-1. Examples of chilblain lesions seen in Aicardi-Goutières syndrome 
patients. Adapted from Crow (2008) [31]. 
 
It has been known that AGS can be caused by mutations in any of six genes, which are 
TREX1 (3’5’  x    l    ), S MHD1 ( NTP    ph  ph     ),  D R1 (RN -editing 
enzyme), RNASEH2A, RNASEH2B, and RNASEH2C (Subunits of type 2 ribonuclease) 
[7, 8, 9, 10]. Even though the exact mechanism of causing AGS has not been identified, it 
is clear that all the six genes are directly or indirectly associated with removal of nucleic 
acids. Therefore, a failure of removing nucleic acids has been considered as primary 
cause of the disease. In 2009, Crow and Rehwinkel speculated that an aberrant 
accumulation of nucleic acids, such as DNAs, RNAs, and RNA-DNA hybrids arising 
from incomplete nucleic acids removal brings about induction of autoimmunity by IFN- 











Figure 1-2. Model of AGS outbreak in the absence of AGS-related genes. Adapted 
from Crow (2009) [3]. 
 
The accumulation of nucleic acids might be detected by some unknown sensors, and an 
induction signal would be transmitted to type I interferon via interferon transcription 
factor3 (IRF3) so that the brain could be damaged by the activated interferon. To develop 
treatments for AGS, interrupting each step of AGS-causing pathways was possibly 
suggested (Figure 1-3). 
Despite many efforts in AGS research, any cure has not been discovered yet. However, 
some treatments with anti-interferon and anti-inflammatory therapies are thought to 














Figure 1-3. Steps in the pathogenesis of AGS which might be discontinued by 











1.2 RIBONUCLEASE H 
Ribonucleases H (RNases H) are a group of endonucleases that hydrolyze the RNA in 
RNA/DNA hybrids in a non-sequence specific manner [3]. RNases H are classified into 
type 1 RNases H (or RNases H1) and type 2 RNases H (or RNases H2) according to 
primary amino acid sequence and biochemical properties on substrate [12]. It is known 
that RNases H contribute to genome integrity by removing ribonucleotides which are 
mistakenly incorporated into DNA strands. RNases H1 require at least four 
ribonucleotides to function appropriately. In contrast, RNases H2 are able to cleave even 
a single ribonucleotide (Figure 1-4) [12, 13]. Most organisms have at least one type of 
RNases H. In addition, RNases H are indispensable enzymes for multicellular eukaryotes 








Figure 1-4. Distinct cleavage patterns of RNase HI/1 and RNase HII/2 on different 




1.2.1 RNASES H1 
RNase H1 is an endonuclease enzyme cleaving the RNA of RNA/DNA heteroduplexes 
[13]. At least four ribonucleotides are required for this enzyme to function in removal of 
RNA. RNase H1 plays a critical role in DNA replication, recombination, repair, and 
trancscription [13, 14]. The N-terminal domain of RNase H1 is referred to as hybrid-
binding domain (HBD) [15, 16], which grants more affinity to RNA/DNA hybrids than 
the same sequence of double-stranded RNA in terms of substrate preference. By forming 
a strong connection with RNA/DNA duplexes, the HBD aids the catalysis of RNase H 
domain [17]. In contrast to RNase H2, mutations in RNase H1 do not cause AGS. 
 
1.2.2 RNASES H2 
In yeast, RNase H2 (or RNase H35) is another essential repair enzyme, whose main role 
is the removal of ribonuleotides from DNA. [13]. However, unlike RNase H1, RNase H2 
consists of three different subunits: RNase H2A, RNase H2B, and RNase H2C (RNH201, 
RNH202, and RNH203 in yeast Saccharomyces cerevisiae, respectively). RNase H2A, 
the catalytic subunit, interacts with the other subunits, non-catalytic subunits, to cleave 
ribonucleotides embedded in DNA duplex [18]. By binding to RNase H2A subunit, 
RNase H2B and H2C act as a platform to assist the cleavage mechanism [11]. It is also 
found that RNase H2B includes PCNA-interacting peptide (PIP) to bind proliferating cell 
unclear antigen (PCNA), which is an indispensable protein for DNA replication/repair as 
well as Okazaki fragment processing during lagging strand synthesis in Eukaryotes[12, 
13]. Type 2 RNases H are able to cleave even a single ribonucleotide mistakenly 
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incorporated in a RNA-DNA hybrid. In general, this type of RNases H is known to 
contribute to genome stability by helping DNA repair. However, the damages arising 
from mutations in RNases H2 can cause severe diseases, such as AGS [3, 13].  It has 
been proposed that a failure in removing ribonucleotides by RNases H2 induce an 
aberrant accumulation of RNA/DNA hybrids, which triggers IFN-α upregulation that 
could damage the brain in the non-viral environment (Figure 1-5) [3, 10].  AGS can be 
caused by mutations in each subunit of RNase H2, especially mutations in RNase H2B 
among all RNase H subunits are found most frequently in people with AGS. The 









Figure 1-5. A suggested AGS-causing model when RNases H2 are deficient. Adapted 




1.3 AGS-RELATED MUTATIONS FOUND IN HUMAN RNASES H2 
Crow, Jackson, and Rice research teams revealed that several AGS-related mutations in 
RNase H2 subunits are commonly found from AGS patients (Figure 1-6) [5, 19]. It was 
suggested that the G37S mutant protein in RNASEH2A lost most RNase H activity due 
to the substitution nearby the catalytic center. Furthermore, some other mutant proteins 
are found in the non-catalytic subunits RNASE H2B and RNASEH2C. Surprisingly, the 
R69W substitution showed reduced RNase H activity like the G37S substitution, but 
other substituted mutant proteins did not differ from their wild type enzymes. This 
observation may be explained by the fact that these proteins are involved in RNase H2 








Figure 1-6. A diagram of the three subunits in Human RNase H2. AGS-related 
mutations are shown on the top of each subunit. Catalysis-involved amino acids are 
shown on the bottom in RNASEH2A and PIP in RNASEH2B. Adapted from Cerritelli 




1.4 SIMILARITY BETWEEN HUMAN AND S. CEREVISIAE RNASES H2 
There are some conserved amino acid sequences between human and yeast S. cerevisiae 
RNase H2 (Figure 1-7). Therefore, it is possible to characterize some of the AGS 













Figure 1-7. Comparison of conserved amino acid sequences of human and S. 




1.5 RNA-DNA HYBRIDS  
In cells, RNA-DNA hybrids are readily found in a variety of processes including R-loops 
during transcription, replication of telomeres, hydrolysis of Okazaki fragment RNA 
primer, and RNA-driven repair [20, 21, 22, 23, 24]. Moreover, RNA-DNA hybrids can 
also form extra-chromosomally as intermediate structures during reverse transcription 
and generation of cDNA [25]. In yeast S. cerevisiae, transposons of yeast (Ty) synthesize 
cDNA by reverse transcription, some of which is transported into the nucleus and is 
integrated into the genome [26]. This process refers to retrotransposition. 
 
1.6 TY1 RETROTRANSPOSONS 
Retrotransposons are transposable elements that can transfer or copy their DNA by 
reverse transcription within a cell. Generally, a large number of eukaryotes have various 
types of transposons. Retrotransposons utilize reverse transcriptase to generate cDNA to 
be integrated into the genome for retrotransposition. Ty1 retrotransposon is one of the 
five transposable elements found in S. cerevisiae and affiliated with long terminal repeat 
(LTR) retrotransposons, which are located on both ends of the element. Ty1 
retrotransposons is the most highly repeated Ty element in laboratory strains of S. 
cerevisiae, and nearly 25-35 copies of Ty1 elements present per haploid genome. 
Interestingly, Ty1 elements have similarities with retroviruses in terms of genome 
organization and replication [27]. Ty1 elements consist of two genes: TY1A, and TY1B, 





Figure 1-8. Genome organization of Ty1 element in S. cerevisiae. I  h      l  (δ) LTR  
at the ends of the element. (PR: protease, IN: integrase, RT: reverse transcriptase, and RH: 
RNase H). 
 
 TY1A proteins form a circle shape of structure with virus-like particles (VLPs). TY1B 
protein is divided into four different domains that are protease, integrase, reverse 
transcriptase, and RNase H. Ty1 elements and retroviruses amplify their DNA in a 
similar way. However, because Ty1 elements do not have env gene, which has an 
infiltration ability to target membranes, they are not infective. Retrotransposition of Ty1 
elements is initiated with transcription of the elements (Figure 1-9). The 
retrotransposition of Ty1 element is temperature sensitive. The optimal temperature of 
the retrotransposition is 22 ℃, and it is possible to detect at 30 ℃, but over 34 ℃ because 
at high temperature, inhibited processing of the TY1A/1B polyprotein and reduced 










Figure 1-9. Retrotransposition cycle of Ty1 retrotransposons in S. cerevisiae. The 
transcribed Ty1-mRNA is transported to the cytoplasm to be translated into TY1A and 
TY1A/1B complex proteins. The Ty1-mRNA and TY1A/1B complex proteins are packed 
together within the VLPs, and subsequently TY1A/1B proteins are cleaved by protease. 
The synthesized cDNA from the Ty1-mRNA is randomly transferred into the nucleus to 









1.7 RESEARCH GOALS & SIGNIFICANCE  
We hypothesized that increased stability of extra-chromosomal RNA-DNA hybrid 
structures due to defects in RNases H could be a main cause to stimulate the autoimmune 
system in AGS. If this hypothesis is correct in RNases H defective cells, there should be 
abundant RNA-DNA heteroduplexes, such as those generated by reverse transcription of 
active retrotransposons in human cells. Because yeast cells also have retrotransposons, 
we aimed to test whether defects in RNases H affects Ty1 retrotransposition activity in 
yeast. The aims of the current study are: 
1. Setting up and testing suitability of a retrotransposition assay in our cells 
- We planned to set up a Ty1 retrotransposition assay, originally designed by 
Curcio and Garfinkel in our yeast strains. We planned to perform the Ty1 
retrotransposition assay both in the absence and in the presence of Ty 
retrotransposition suppressing factors and test its functionality.    
2. Performing the retrotransposition assay with RNase H mutants including AGS-
realated RNase H2 mutants 
- We planned to examine whether yeast cells with defective forms of RNases H 
and AGS-orthologous mutants of RNase H2 had altered retrotransposition 
activity compared with cells with wild-type RNases H. 
The findings obtained from this study would help to reveal the unknown mechanism of 
the AGS associated with RNases H. In addition, this study could be helpful in future 





MATERIALS AND METHODS 
2.1 PLASMIDS 
The core plasmid in the study was pBDG598 (Figure 2-1). This plasmid is also known as 
pGTy1mhis3-AI [29, 30]. The pBDG598 plasmid was introduced into in the yeast strains 
of the wild-type, RNases H-null and AGS-orthologous mutants. Once the GAL1 promoter 
is induced by galactose, a pre Ty1-mRNA structure including Ty1 gene and his3 gene 
interrupted by an artificial intron (AI) is produced. By processing, the AI is spliced out, 
and the HIS3 gene is restored in the RNA script. Once the synthesized cDNA by RT is 
integrated by retrotransposition into the genome, His
+










Figure 2-1. A diagram of plasmid pBDG598 used in this study. URA3 is used as the 
main marker of the plasmid. Under the control of GAL1 promoter, Ty gene is expressed. 
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The artificial intron (AI) inserted in the middle of his3 gene is in the antisense orientation 
relative to the HIS3 gene. Adapted from Derr and Starthern (1993) [30]. 
 
We also transformed pSM50 and pBDG102 plasmids into our strains (Figure 2-2). The 
pSM50 plasmid has the GAL1 promoter and disrupted his3 gene but Ty1 element. 
Consequently, the restored HIS3 cannot be integrated into the genome by 
retrotransposition, but it could happen with homologous recombination or other 
mechanisms [30]. From the strains including the pBDG102, any HIS
+
 colony is not 
observed on SC-His
-
 medium as the plasmid has only the GAL1promoter.  
 
Figure 2-2. A diagram of pSM50 and pBDG102 plasmids used for negative controls 
in the study. (A) pSM50: due to the lack of Ty gene including an integrase domain, the 
his3 gene interrupted by the AI cannot be restored. However, some of the yeast strains 
often show His
+
 colonies on SC-His
-
 medium by possibly homologous recombination or 
unknown mechanisms. (B) pBDG102: no gene exists under the downstream of GAL1 




TABLE 1. Yeast Strains used in this study. 
Strain Genotype Plasmid Source 
TY 1-1, 1-2 MATα  his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0 pBDG102 this study 
TY 2-1, 2-2 MATα  his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0 pBDG598 this study 
TY 3-1, 3-2 MATα  his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0 pSM50 this study 
TY-17, 53 MATα  his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0 trp5 pBDG598 this study 
TY-18, 56 MATα  his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0 trp5 rnh201Δ::kanMX4 pBDG598 this study 
TY-19, 58 MATα  his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0 trp5 rnh201-G42S pBDG598 this study 
TY-20, 61 MATα  his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0 trp5 rnh203-K46W pBDG598 this study 
TY-21, 64 MATα  his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0 trp5 rnh1Δ::hygMX4 pBDG598 this study 
TY-22, 67 MATα  his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0 trp5 rnh1Δ::hygMX4 rnh201Δ::kanMX4 pBDG598 this study 
TY-23, 70 MATα  his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0 trp5 rnh201-G42S rnh1Δ::hygMX4 pBDG598 this study 
TY-24, 73 MATα  his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0 trp5 rnh203-K46W rnh1Δ::hygMX4 pBDG598 this study 
TY-32, 52 MATα  his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0 trp5 pBDG102 this study 
TY-33, 57 MATα  his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0 trp5 rnh201-G42S pBDG102 this study 
TY-34, 60 MATα  his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0 trp5 rnh203-K46W pBDG102 this study 
TY-35, 63 MATα  his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0 trp5 rnh1Δ::hygMX4 pBDG102 this study 
TY-36, 66 MATα  his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0 trp5 rnh1Δ::hygMX4 rnh201Δ::kanMX4 pBDG102 this study 
TY-37, 69 MATα  his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0 trp5 rnh201-G42S rnh1Δ::hygMX4 pBDG102 this study 
TY-38, 72 MATα  his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0 trp5 rnh203-K46W rnh1Δ::hygMX4 pBDG102 this study 
TY-55, 75 MATα  his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0 trp5 rnh201Δ::kanMX4 pBDG102 this study 
TY-126. 127 MATα  his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0 trp5 pBDG102 this study 
TY-128, 129 MATα  his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0 trp5 pBDG598 this study 
TY-130, 131 MATα  his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0 trp5 pBDG598 this study 
S. cerevisiae strains used in the study.  
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As explained in Figure 1-7, we constructed AGS-related mutants in S. cerevisiae by 
amino acid substitution, using the similarity between human and yeast RNase H2 
subunits (Figure2-3). The G37S and R69W in human RNase H2 were converted to the 
G42S and K46W in yeast RNase H2, respectively. 
 
 
Figure 2-3. Construction of AGS-related mutant strains in yeast S. cerevisiae. (G: 
glycine, S: serine, R: Arginine, W: Tryptophan, and K: Lysine). Adapted from Cerritelli 









2.3 SCHEME OF PATCHING ASSAY 
Replica plate Ura
+
 patches onto SC-His
-
 medium and SC-Ura
- 
medium with 2% galactose 
and incubate at 22 ℃ (96 hr) or 30 ℃ (48 hr), as indicated (Figure 2-4). Then, replica 



















2.4 SCHEME OF LIQUID ASSAY 
Inoculate strains in SC-Ura
- 
liquid medium and incubate at 30 ℃ overnight. Transfer 106 
cells into SC-Ura
-  
liquid medium and SC-Ura
-
 liquid medium with 2% galactose and 







 media to detect His
+
 colonies (Figure 2-5).  
  












3.1 CONSTRUCTION OF RNASES H-NULL AND AGS-RELATED MUTANT 
STRAINS CONTAINING TY1 ELEMENT 
We previously generated defective forms of RNase H mutant strains in yeast S. cerevisiae 
by replacing RNase H genes with antibiotic cassettes (rnh1::hygMX4 and 
rnh201::kanMX4). In addition, as shown in Figure 2-3 [29], we constructed a couple of 
AGS-related mutant strains in yeast (rnh201-G42S and rnh203-K46W). From the AGS-
related mutant strains, we also knocked out RNH1 (rnh201-G42S rnh1::hygMX4 and 
rnh203-K46W rnh1::hygMX4). To observe Ty1 retrotrasposition activity from these 
strains, we introduced a plasmid, pBDG598, which expresses the Ty1 retrotransposon 
fused to an inverted copy of the his3 gene interrupted by an artificial intron (AI), which is 
in the antisense orientation relative to the his3 gene, and the Ty1 element and the fused 
his3 gene are expressed by the GAL1 inducible promoter (Figure 2-1). As negative 
controls, pBDG102 and pSM50 plasmids, which lack the Ty1 element (Figure 2-2) [29], 
were also introduced into the strains. Both of the pBDG102 and pSM50 have the GAL1 
promoter in common, but only pSM50 has the disrupted his3 gene. As the three plasmids 
include an URA3 gene as a marker, we initially screened and made Ura
+ 
patches of the 






3.2 THE RETROTRANSPOSITION ASSAY WORKS IN OUR STRAINS 
To test if the retrotranposition assay works in our yeast strain, we performed 
retrotransposition patching assay with the wild-type RNases H, containing pBDG102 
(negative control NC), pBDG598 (Ty plasmid), pSM50, respectively (Figure 3-1). Each 
of the strains was patched onto SC-Ura
-
 medium. The Ura
+
 patches were then replica 








) media to see the 
difference between results when the GAL1 promoter is induced and when it is not. The 





) medium to observe His
+
 colonies due to the retrotransposition of the 
Ty1 fused to the his3 gene. We found that no His
+
 colonies were generated from the 
strains containing pBDG102 without the Ty1 element, even in the presence of activated 
GAL1 promoter (Figure 3-1A, B, and C). In contrast to NC, the wild-type strains 
containing the Ty plasmid and pSM50 showed few His
+
 colonies on His
-
 medium in the 
absence of galactose likely due to the leaky nature of the GAL1 promoter. When the 
GAL1 promoter was induced, we observed high retrotransposition frequencies only for 
the strains containing the Ty plasmid compared to the strains containing the control 
plasmid (Figure 3-1B, and C). As explained earlier, because high temperature down-
regulates the processing of TY1A/1B protein and reverse transcriptase activity [28], more 
His
+
 colonies were observed on the His
- 
medium, when cells were replica plated from the 
GalUra
-
 medium and incubated at 22 ℃. Overall, these findings ensured that our 
retrotransposition assay is applicable to detect the retrotransposition activity of the Ty1 




Figure 3-1. Result of retrotransposition patching assay with the wild-type. Replica-
plated Ura
+ 
patches from (A) SC-Ura
-
 (+ Glucose), (B) SC-Ura
-
 (+ 2% Galactose), 
incubated at 30 ℃ and (C) SC-Ura- (+ 2% Galactose), incubated at 22 ℃, to SC-His- 













3.3 PHOSPHONOFORMATE (PFA) STRONGLY REDUCES THE TY1 
RETROTRANSPOSITION 
We tested our retrotransposition assay with Phosphonoformate (PFA), a reverse 
transcriptase inhibitor [33], to confirm that the His
+
 colonies found on the His
-
 medium 
come from the outcome of the Ty1 retrotransposition. The Ura
+ 
patches of the wild-type 




 medium with none, 1.0 mg/ml, and 2.5 
mg/ml of PFA, respectively. Then, the patches were replica plated onto His
-
 medium 
once again after galactose induction. We found that the Ty1 retrotransposition was 
completely inhibited by PFA when cells were incubated at 30 ℃ (Figure 3-2C and D). 
Similarly, very few of His
+
 cells grew on the His
-
 medium when cells were incubated at 












Figure 3-2. Result of retrotransposition patching assay with the wild-type in the 
presence of PFA. Replica-plated Ura
+
 patches from (A) Ura
-
 medium in the absence of 
PFA, (B-D) GalUra
-
medium in the presence of PFA as indicated, incubated at 30 ℃, (E-
G) GalUra
-
 medium, incubated at 22 ℃ to His- medium. 
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To verify and quantify the results shown in the patching assay, we also performed the 
retrotransposition liquid assay with our strains (Figure 3-3). The Ura
+
 patches of the 
wild-type strains were initially incubated in Ura
-
 liquid medium at 30 ℃ for 24 hr. Then, 




 medium, and grew at 22 ℃ 
for 96 hr or at 30 ℃ for 48 hr. Later, cells were plated on His-Ura- and Ura- media. The 
number of the His
+
 cells grown in GalUra
-
 liquid medium with PFA (1.0 mg/ml) was 
reduced about 15-fold compared to that grown in GalUra
-
 medium without PFA at 30 ℃ 
(Figure 3-3A), and when cells were incubated at 22 ℃, more than 1,500-fold (Figure 3-
3B).  
Based on the results that retrotransposition activity was weakened in the presence of the 
reverse transcriptase inhibitor PFA, we concluded that the PFA strongly represses HIS3 
cDNA synthesis resulting in retrotransposition of the Ty1 element in our yeast strain 










Figure 3-3. Result of retrotransposition liquid with the wild-type in the presence of 
PFA. The amount of grown His
+
 cells in liquid media in the presence or absence of PFA 
incubated (A) at 30 ℃ or (B) at 22 ℃. The bars indicate the median values with range. 
The significant fold change is indicated on the top of the bars. The significance of 
comparisons between the strains was calculated using the Mann-Whitney U test * 
significant    p ≤ 0.05; **   g  f         p ≤ 0.01. (  = 6). 
 
 






3.4 RETROTRANSPOSITION IS PARTIALLY DECREASED IN THE ABSENCE 
OF DBR1 ENZYME    
Dbr1 is an RNA lariat   b    h  g   z     h    l  v    h  2’-5’ ph  ph         l  k g  
at the branch point of lariat intron pre-mRNAs after splicing. And then, it converts them 
into linear molecules that are subsequently degraded [34]. A study of Chapman (1991) 
revealed that dbr1-null mutant in yeast cells impairs cDNA formation and diminishes Ty 
transposition up to 10-fold [34]. We further confirmed that our retrotrasposition assay 
results arose from cDNA synthesized during reverse transcription by knocking out the 
DBR1 gene in our yeast background. Retrotransposition frequency comparison between 
the wild-type and dbr1 knocked-out strains was not clearly distinguishable by looking at 
the patches grown on the His
-
 medium and incubated at 22 ℃ (Figure 3-4C). However, 
we found the number of His
+
 colonies from dbr1-null strains to be significantly less than 
that of the wild-type shown on the His
-







Figure 3-4. Result of retrotransposition patching assay with the wild-type and dbr1 
mutant strains. Replica-plated Ura
+




 incubated at 
30 ℃, and (C) GalUra- medium incubated at 22 ℃.  
27 
 
We also obtained a similar result from the liquid assay in the absence of the Dbr1 (Figure 
3-5). In the dbr1 cells, a 9.1 fold-decrease in the amount of the His
+ 
cells was detected 
from the result of the retrotransposition liquid assay performed at 22 ℃ (Figure 3-5B). 
At the 30 ℃ experiment, we also observed the reduced retrotransposition frequency 
between the wild-type and the dbr1 mutant strains, but modest (Figure 3-5A).  
To sum up, we found that deletion of DBR1 partially reduces retrotransposition activity 













Figure 3-5. Result of retrotransposition liquid assay with the wild-type and dbr1 
mutant strains. The amount of grown His
+
 cells in liquid media in the presence or 
absence of the Dbr1 incubated (A) at 30 ℃ or (B) at 22 ℃. The bars indicate the median 
values with range. The significant fold change is indicated on the top of the bars. The 
significance of comparisons between the strains was calculated using the Mann-Whitney 
U test * significant    p ≤ 0.05; **   g  f         p ≤ 0.01. (  = 6). 
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3.5 TY1 RETROTRANSPOSITION ACTIVITY IS REPRESSED BY THE 
DELETION OF RNASES H1 AND H2 
We then examined how RNases H and AGS-related mutant strains affect the 
retrotransposition of the Ty1 element through our retrotransposition assay. Each time we 
performed the patching assay we found a few His
+
 colonies for the rnh1 rnh201 double 
knocked-out mutant strain even though the GAL1 promoter was not induced (Figure 3-
6A). We assumed that this result could be retrotransposition or gene conversion due to 
the leakiness of the GAL1 promoter. Because of the enhanced retrotransposition activity 
in galactose when cells were incubated at low temperature, we could not find any 
difference among the mutant strains compared to the RNase H wild-type strain (Figure 
3-6C). Differently, when cells were grown on GalUra
- 
medium and incubated at 30 ℃, it 
was found that the retrotransposition frequency was reduced when RNase H2 was deleted 
alone, or it was deleted together with RNase H1 (Figure 3-6B). The rnh1-null and AGS-
orthologous mutant strains also showed slightly decreased retrotransposition frequencies 




Figure 3-6. Result of retrotransposition patching assay with the wild-type, RNases 
H-null, and AGS-related mutant strains. Replica-plated Ura
+





 incubated at 30 ℃, and (C) GalUra- medium incubated at 22 ℃.  
 
To verify the patching assay result, we performed the liquid assay for the same strains. In 
the test conducted at 30 ℃ using defective forms of RNases H and AGS-related mutant 
strains, five out of seven mutant strains showed reduced number of His
+ 
colonies (Figure 
3-7A). While the rnh1, rnh201, rnh201-G42S rnh1, and rnh203-K46W rnh1 strains 
partially showed decreased retrotransposition frequencies ranging from 1.2 to 3.2 folds as 
shown in the Figure 3-7A, the rnh1 rnh201 double mutant reduced the retrotransposition 
frequency more than 11-fold compared to the wild-type. The result obtained from the 22 ℃ 
assay was fairly consistent with the patching assay result obtained at 30 ℃ (Figure 3-7B). 





compared to the wild-type strain. In addition, rnh1 rnh201 and rnh201-G42S rnh1 
knocked-out strains showed less than 3-fold reduced retrotransposition frequency 
compared to the wild-type strain.  
From the result of both the patching and the liquid assays, rnh201 single and rnh1 rnh201 
double mutants have a significant impact on the retrotransposition activity depending on 
the incubation temperature. The AGS-related mutant strains did not effectively increase 
or decrease the retrotransposition frequency of the Ty1 element, but when knocked out 
together with RNase H1, partially decreased the retrotransposition frequency in the liquid 
assay. The rnh1 mutant strain showed a slight decreased number of His
+
 colonies only in 





Figure 3-7. Result of retrotransposition liquid assay with the wild-type, RNases H-
null, and AGS-related mutant strains.  The amount of grown His
+
 cells in liquid media 
incubated (A) at 30 ℃ or (B) at 22 ℃. The bars indicate the median values with range. 
The significant fold change is indicated on the top of the bars. The significance of 
comparisons between the strains was calculated using the Mann-Whitney U test * 











Aicardi-Goutières syndrome (AGS) is a rare genetic encephalopathy that mimics 
congenital viral infection characterized by increased interferon-α expression. It has been 
found that six gene are involved in AGS. These are TREX1, 3’5’ exonuclease, 
SAMHD1, cellular phosphohydrolase, ADAR1, RNA editing enzyme, and RNase H2 
subunits, which are mutated in more than 50% of affected AGS patients. Mutations 
occurring in both types of RNase H, which cleave both isolated ribonucleotides 
embedded in DNA and RNA-DNA hybrids, can cause AGS. The mechanism of AGS is 
still unclear and no cure for AGS patients has been developed. It remains uncertain which 
function of RNase H2 is associated with AGS in RNase H2 mutants of AGS patients, and 
also there have been no scheme to detect mutation in RNase H1 could be associated with 
AGS. We hypothesized that incomplete work of RNase H2 could lead to accumulations 
of extra-chromosomal RNA-DNA hybrids generated during reverse transcription of 
retrotransposition. In this study, we tried to understand the relation between RNases H 
and yeast retrotransposition in the context of the AGS, using RNase-null and AGS-
related mutant strains of S. cerevisiae.  
Initially, we constructed some mutant strains that are defective forms of RNases H (rnh1, 
rnh201, and rnh1 rnh201). We also generated AGS-related mutant found in AGS patients 
(rnh201-G42S and rnh203-K46W)[13]. We then planned to set up a retrotranposition 
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assay using the Ty1  system developed by Curcio and Garfinkel [29] to detect Ty1 
retrotransposition activity in our yeast strains. We transformed yeast cells with a 
recombinant DNA plasmid containing Ty1 retroelement fused to a his3 gene, whose 
function is disrupted by an inserted artificial intron in the reverse orientation relative to 
the his3 gene. The activation of the GAL1 promoter upstream of the Ty1 element enables 
retrotransposition  of the Ty1-his3 fusion and then HIS3 cDNA is synthesized through 
reverse transcription.  
In order to test the functionality of the retrotransposition assay, we conducted the 
retrotransposition patching assay with the wild-type RNases H strains at two different 
temperatures (22 ℃ and 30 ℃). The results performed at both temperatures showed many 
numbers of His
+
 colonies grown on His
- 
medium when the GAL1 promoter was activated. 
Due to the improved protease and reverse transcriptase functions, more His
+
 colonies 
were shown when the experiment was conducted at 22 ℃. In contrast, we did not observe 
any His
+
 colonies from the strains with the plasmid lacking of Ty1 element. However, we 
found few His
+ 
colonies from the strains containing pBDG598 and pSM50, which 
contains the only the GAL1 promoter and the his3 gene, in the absence of galactose. This 
was thought to be because of the leaky nature of the GAL1 promoter. These findings 
verified that the Ty1 retrotransposition assay works in our yeast strains. 
We successively performed to test to verify the observed His
+
 colonies where requiring 
reverse transcription step and a cDNA intermediate. In the first test, the wild-type RNase 
H cells were incubated in GalUra
- 
medium containing phosphonoformic acid (PFA) 
inhibiting reverse transcriptase. The result shown from both the patching and liquid 
assays indicated that PFA significantly reduces Ty1 retrotransposition activity.  
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By knocking out the DBR1 gene, which is required for efficient cDNA formation in yeast 
cells [34], we found that the Ty1 retrotransposition frequency is partially but significantly 
reduced in the absence of DBR1 gene.  
Having the established functionality of the Ty1 assay in our yeast strains, we decided to 
perform the retrotransposition assay in the RNase H-null and AGS-orthologous mutant 
strains. We found that rnh201 and rnh1 rnh201 strains showed reduced transposition 
frequency in the patching assay when cells were grown on GalUra
- 
medium and 
incubated at 30 ℃. In the liquid assay performed at 30 ℃ or 22 ℃, we observed that most 
of the strains had decreased Ty1 retrotransposition frequency, except for the AGS-related 
mutants. Importantly, defects in RNase H1 and/or H2 did not increase the frequency of 
Ty1 retrotransposition. Differently, a decrease of the Ty1 retrotransposition frequency 
was apparently observed in rnh201 and rnh1 rnh201 cells and also in rnh201-G42S rnh1 
cells from the results of the liquid assays conducted at both temperatures, and a minor 
decrease of Ty1 retrotransposition frequency was observed in the rnh1 mutant only in the 
test conducted at 30 ℃. Interestingly, most of the time the patching assay was done with 
the rnh1 rnh201 double mutant strain at both temperatures, few of its His
+ 
colonies were 
observed without the GAL1 promoter induction. We guessed it might occur as the GAL1 
promoter is leaky and the retrotransposition of Ty-his3 could be  in the absence of both 
types of RNase H because there should be more cDNA. A contradictive view on this, the 
rnh1 rnh201 mutant apparently showed a decrease of Ty1 retrotransposition activity in 
the presence of galactose but reversely showed His
+
 colonies in the absence of galactose. 
The few His
+
 colonies without galatose induction in the rnh1 rnh201 cells could be due 
to recombination between cDNA and his3 alleles on the plasmid. 
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There are a couple of possible explanations why the Ty1 retrotransposition frequency is 
reduced in the absence of RNases H enzymes. First of all, substrate preference of the 
integrase binding to nucleic acids may delay or inhibit the Ty retrotransposition activity. 
The binding of the intergrase to DNA duplexes could not be selective due to the 
increased abundance of RNA-DNA substrate in RNase H defective cells. However, 
decreased amount of double-stranded DNA can force the integrase to automatically bind 
RNA-DNA hybrids instead of DNA duplexes. The change on substrate of the integrase 
might delay or inhibit the retrotransposition process. Furthermore, if RNA-DNA hybrid 
fragments were potentially integrated into the genome, it also would cause a problem on 
retrotransposition. The integrase may recognize RNA-DNA hybrids as a DNA duplex by 
capturing both pure DNA ends of the strands.   
As part of future work, we plan to identify and quantify extra-choromosomal RNA-DNA 
hybrids of the HIS3 gene from our RNase H defective strains either by Southern blotting 
or with the S9.6 antibody specific to RNA-DNA hybrids. Ultimately, we hope to apply 
our retrotransposition assay in human cell line, such as long interspersed element-1 
(LINE-1), which is a retrotransposable element found in human to observe the 
retrotransposition activity in the defective forms of RNase H. 
Our findings in this study could become a helpful source to unveil the mechanism how 
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